Award Year / Program / Phase:
2012 / STTR / Phase II
Agency:
HHS
Research Institution:
UNIVERSITY OF ALABAMA AT BIRMINGHAM
DESCRIPTION (provided by applicant): This proposal involves the development of a high-throughput self-interaction chromatography (SIC) system that will be used by Soluble Therapeutics, LLC, to improve and accelerate the formulation discovery process for biopharmaceuticals (i.e. vaccines, monoclonal…
More